N-Myc Downstream-Regulated Gene 4 ( NDRG4 ): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer

Autor: Frank A. Oort, Silvia Sanduleanu, Iris E. J. M. Partouns-Hendriks, Sandra M. van den Bosch, Carolina A.J. Khalid-de Bakker, Adriaan P. de Bruïne, Gerrit A. Meijer, Matty P. Weijenberg, James G. Herman, Veerle Melotte, Kathleen L.J. Daenen, Kim M. Smits, Marjolein H.F.M. Lentjes, Daisy Jonkers, Debby M.E.I. Hellebrekers, Kim A.D. Wouters, Manon van Engeland, Joost Louwagie, Joep P.J. de Hoon, Filip Stessels
Přispěvatelé: Gastroenterology and hepatology, Pathology, CCA - Oncogenesis, Pathologie, Interne Geneeskunde, Epidemiologie, RS: NUTRIM - R2 - Gut-liver homeostasis
Rok vydání: 2009
Předmět:
Zdroj: Journal of the National Cancer Institute, 101(13), 916-927. Oxford University Press
Journal of the National Cancer Institute, 101(13), 916-27. Oxford University Press
Melotte, V, Lentjes, M H F M, Bosch, S M, Hellebrekers, D M E I, de Hoon, J P J, Wouters, K A D, Daenen, K L J, Partouns-Hendriks, I E J M, Stessels, F, Louwagie, J, Smits, K C M, Weijenberg, M P, Sanduleanu, S, Bakker, C, Oort, F A, Meijer, G A, Jonkers, D M A E, Herman, J, Bruine, A & van Engeland, M 2009, ' N-Myc Downstream-Regulated Gene 4 (NDRG4): A Candidate Tumor Suppressor Gene and Potential Biomarker for Colorectal Cancer ', Journal of the National Cancer Institute, vol. 101, no. 13, pp. 916-927 . https://doi.org/10.1093/jnci/djp131
ISSN: 1460-2105
0027-8874
DOI: 10.1093/jnci/djp131
Popis: BACKGROUND: Identification of hypermethylated tumor suppressor genes in body fluids is an appealing strategy for the noninvasive detection of colorectal cancer. Here we examined the role of N-Myc downstream-regulated gene 4 (NDRG4) as a novel tumor suppressor and biomarker in colorectal cancer. METHODS: NDRG4 promoter methylation was analyzed in human colorectal cancer cell lines, colorectal tissue, and noncancerous colon mucosa by using methylation-specific polymerase chain reaction (PCR) and bisulfite sequencing. NDRG4 mRNA and protein expression were studied using real-time-PCR and immunohistochemistry, respectively. Tumor suppressor functions of NDRG4 were examined by colony formation, cell proliferation, and migration and invasion assays in colorectal cancer cell lines that were stably transfected with an NDRG4 expression construct. Quantitative methylation-specific PCR was used to examine the utility of NDRG4 promoter methylation as a biomarker in fecal DNA from 75 colorectal cancer patients and 75 control subjects. All P values are two-sided. RESULTS: The prevalence of NDRG4 promoter methylation in two independent series of colorectal cancers was 86% (71/83) and 70% (128/184) compared with 4% (2/48) in noncancerous colon mucosa (P < .001). NDRG4 mRNA and protein expression were decreased in colorectal cancer tissue compared with noncancerous colon mucosa. NDRG4 overexpression in colorectal cancer cell lines suppressed colony formation (P = .014), cell proliferation (P < .001), and invasion (P < .001). NDRG4 promoter methylation analysis in fecal DNA from a training set of colorectal cancer patients and control subjects yielded a sensitivity of 61% (95% confidence interval [CI] = 43% to 79%) and a specificity of 93% (95% CI = 90% to 97%). An independent test set of colorectal cancer patients and control subjects yielded a sensitivity of 53% (95% CI = 39% to 67%) and a specificity of 100% (95% CI = 86% to 100%). CONCLUSIONS: NDRG4 is a candidate tumor suppressor gene in colorectal cancer whose expression is frequently inactivated by promoter methylation. NDRG4 promoter methylation is a potential biomarker for the noninvasive detection of colorectal cancer in stool samples.
Databáze: OpenAIRE
Externí odkaz: